- Home
- GNSS vs ETON Comparison
GNSS vs ETON Comparison
Compare GNSS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ETON
- Stock Information
- Founded
- GNSS 1992
- ETON 2017
- Country
- GNSS United States
- ETON United States
- Employees
- GNSS N/A
- ETON N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ETON Health Care
- Exchange
- GNSS Nasdaq
- ETON Nasdaq
- Market Cap
- GNSS 78.1M
- ETON 388.3M
- IPO Year
- GNSS N/A
- ETON 2018
- Fundamental
- Price
- GNSS $1.96
- ETON $14.85
- Analyst Decision
- GNSS Strong Buy
- ETON Strong Buy
- Analyst Count
- GNSS 3
- ETON 3
- Target Price
- GNSS $5.33
- ETON $29.67
- AVG Volume (30 Days)
- GNSS 131.5K
- ETON 621.3K
- Earning Date
- GNSS 08-05-2025
- ETON 08-07-2025
- Dividend Yield
- GNSS N/A
- ETON N/A
- EPS Growth
- GNSS N/A
- ETON N/A
- EPS
- GNSS N/A
- ETON N/A
- Revenue
- GNSS $27,780,000.00
- ETON $48,327,000.00
- Revenue This Year
- GNSS $91.14
- ETON $103.21
- Revenue Next Year
- GNSS $75.44
- ETON $51.34
- P/E Ratio
- GNSS N/A
- ETON N/A
- Revenue Growth
- GNSS N/A
- ETON 40.88
- 52 Week Low
- GNSS $1.46
- ETON $3.25
- 52 Week High
- GNSS $4.04
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- GNSS 70.78
- ETON 54.31
- Support Level
- GNSS $1.48
- ETON $13.78
- Resistance Level
- GNSS $1.85
- ETON $16.27
- Average True Range (ATR)
- GNSS 0.10
- ETON 0.83
- MACD
- GNSS 0.05
- ETON 0.32
- Stochastic Oscillator
- GNSS 98.11
- ETON 77.67
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.